Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Bioprotect Ltd |
| Country | Israel |
| Start Date | Oct 01, 2023 |
| End Date | Sep 30, 2025 |
| Duration | 730 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190160766 |
Prostate is the 2nd leading cancer in men in the world, with more than 1.4 million men diagnosed every year globally. ~50% of men will be treated with radiation treatment.
Radiation is a highly effective treatment; however, it has significant complications, mainly injuring the rectal tissue, approximate to the prostate treatment area.
Up to 35% of the patients will experience rectal toxicity side effects such as bleeding, urinary, bowl and erectile dysfunction, damaging severely patients quality of life. There is a growing need for a solution that protects the rectum from the radiation field.
Our soluton ProSpace is a biodegradable medical grade copolymer (70:30 Poly L-Lactide-co--Caprolactone) balloon spacer deployed in the prostate-rectum interspace.
It creates a 1.8cm, symmetric distance between the prostate & rectum, allowing physicians to radiate prostate tumours & sparing healthy rectal tissue.
Bioprotect Ltd
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant